These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 31602823)
21. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure. Khan AU; Khan M; Cho MH; Khan MM Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755 [TBL] [Abstract][Full Text] [Related]
22. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis. Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903 [TBL] [Abstract][Full Text] [Related]
23. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Kemp JA; Shim MS; Heo CY; Kwon YJ Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465 [TBL] [Abstract][Full Text] [Related]
25. Nanomedicines for Renal Management: From Imaging to Treatment. Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331 [TBL] [Abstract][Full Text] [Related]
26. Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy. Liao J; Jia Y; Wu Y; Shi K; Yang D; Li P; Qian Z Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1581. PubMed ID: 31429208 [TBL] [Abstract][Full Text] [Related]
27. Pulmonary delivery systems for polyphenols. Trotta V; Scalia S Drug Dev Ind Pharm; 2017 Jul; 43(7):1043-1052. PubMed ID: 28276786 [TBL] [Abstract][Full Text] [Related]
31. Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: Critical appraisal of newer developments and challenges to clinical transition. Gao X; Guo L; Li J; Thu HE; Hussain Z J Control Release; 2018 Dec; 292():29-57. PubMed ID: 30359665 [TBL] [Abstract][Full Text] [Related]
33. Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease. Seshadri DR; Ramamurthi A Front Pharmacol; 2018; 9():759. PubMed ID: 30061830 [TBL] [Abstract][Full Text] [Related]
34. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment. Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269 [TBL] [Abstract][Full Text] [Related]